givosiran (ALN-AS1)
ALN-AS1-001
Phase 1 small_molecule completed
Quick answer
givosiran (ALN-AS1) for Acute Intermittent Porphyria is a Phase 1 program (small_molecule) at Alnylam Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alnylam Netherlands B.V.
- Indication
- Acute Intermittent Porphyria
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed